 Here, the authors characterize a SARS-CoV-2 subunit vaccine candidate that contains full-length spike protein stabilized in its pre-fusion confirmation, and show immunogenicity in baboons and protection in mice with Matrix-M adjuvant vaccine. This article was authored by Jinghui Qian, Nita Patel, Robert Horped, and others.